They determined that prostate stem cell antigen was overexpressed in pancreatic cancer and confirmed this finding by subsequent RT–PCR and immunohistochemistry analyses of primary pancreatic cancer specimens. The gene discussed is PSCA; the disease is pancreatic neoplasm.